Pre-eclampsia (PE) is high blood pressure caused by pregnancy. It is one of the most common & life threatening conditions occurring in pregnancy and affects around 1 in 20 pregnant women. Screening is simple way to identify those women at risk of developing early-onset pre-eclampsia. Early detection and treatment can improve pregnancy outcomes. Screening for Early-onset Pre-eclampsia (EO-PE) is offered by VCGS as an option with the Combined First Trimester Screening (CFTS) - patients must 'opt-in' on the test request form. Screening uses the same blood sample collected for CFTS.
As of August 14th 2017:
- For Combined First Trimester Screening (CFTS), the out-of-pocket range is $92-$101 (Item #66750)
- For Combined First Trimester Screening (CFTS) with Early-Onset Pre-eclampsia, the out-of-pocket range is $111-$120 (Item #66750)
- For Second Trimester Screening (2TMSS), the out-of-pocket range is $79-$88 (Item #66751)
Phone 1300 934 355 (Lab)
Plain tube or serum gel 7 ml
Samples for PE screening must be collected between 11+0 and 13+6 weeks.
EDTA or Heparinised blood is unacceptable.
If there is a delay in transport, separate and freeze serum at -20 degrees celsius.
Patients taking large doses of biotin (>10mg per day) should cease this intake one day prior to blood collection for this test.